MedTrace Logo

Validity and Reliability of Indonesian Translated Ages and Stages Questionnaires - Third Edition (ASQ-3) as a Screening Tool for Developmental Delay in 1-12 Months Old Children

NCT05398900 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 245

Last updated 2022-06-01

No results posted yet for this study

Summary

This study aimed to provide the validity and reliability of the Indonesian ASQ-3 questionnaires as a screening tool for developmentally delayed children aged less than one year old. This study was divided into 2 phases. The first phase (April-June 2018) included the transcultural adaptation of the ASQ-3 questionnaires for 2 to 12 months age groups from English to Indonesian. The second phase (July- September 2018) included a cross-sectional study of Indonesian ASQ-3 questionnaires for parents/caregivers of children aged 1-12 months, with 35 children in each age group by cluster sampling methods, in 2 district areas in East Jakarta.

Conditions

  • Developmental Delay
  • Child Development
  • Child Development Disorder
  • Global Developmental Delay
  • Infant Development
  • Motor Delay
  • Speech Delay
  • Communication Disorders
  • Development Delay

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05398900 on ClinicalTrials.gov